132 related articles for article (PubMed ID: 38488146)
1. Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1.
Imhoff RD; Patel R; Safdar MH; Jones HBL; Pinto-Fernandez A; Vendrell I; Chen H; Muli CS; Krabill AD; Kessler BM; Wendt MK; Das C; Flaherty DP
J Med Chem; 2024 Mar; 67(6):4496-4524. PubMed ID: 38488146
[TBL] [Abstract][Full Text] [Related]
2. Development of Ubiquitin Variants with Selectivity for Ubiquitin C-Terminal Hydrolase Deubiquitinases.
Hewitt CS; Krabill AD; Das C; Flaherty DP
Biochemistry; 2020 Sep; 59(37):3447-3462. PubMed ID: 32865982
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine-Based Inhibitor.
Krabill AD; Chen H; Hussain S; Feng C; Abdullah A; Das C; Aryal UK; Post CB; Wendt MK; Galardy PJ; Flaherty DP
Chembiochem; 2020 Mar; 21(5):712-722. PubMed ID: 31449350
[TBL] [Abstract][Full Text] [Related]
4. Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.
Krabill AD; Chen H; Hussain S; Hewitt CS; Imhoff RD; Muli CS; Das C; Galardy PJ; Wendt MK; Flaherty DP
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668938
[TBL] [Abstract][Full Text] [Related]
5. Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3.
Hewitt CS; Das C; Flaherty DP
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053210
[TBL] [Abstract][Full Text] [Related]
6. The co-crystal structure of ubiquitin carboxy-terminal hydrolase L1 (UCHL1) with a tripeptide fluoromethyl ketone (Z-VAE(OMe)-FMK).
Davies CW; Chaney J; Korbel G; Ringe D; Petsko GA; Ploegh H; Das C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3900-4. PubMed ID: 22617491
[TBL] [Abstract][Full Text] [Related]
7. Expression of ubiquitin-related enzymes in the suprachiasmatic nucleus with special reference to ubiquitin carboxy-terminal hydrolase UchL1.
Dong X; Yagita K; Zhang J; Okamura H
Biomed Res; 2005 Apr; 26(2):43-9. PubMed ID: 15889617
[TBL] [Abstract][Full Text] [Related]
8. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
Graham SH; Liu H
Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin C-Terminal Hydrolase L1 regulates autophagy by inhibiting autophagosome formation through its deubiquitinating enzyme activity.
Yan C; Huo H; Yang C; Zhang T; Chu Y; Liu Y
Biochem Biophys Res Commun; 2018 Mar; 497(2):726-733. PubMed ID: 29462615
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.
Hu Y; Qi C; Shi J; Tan W; Adiljan Abdurusul ; Zhao Z; Xu Y; Wu H; Zhang Z
Cell Mol Life Sci; 2023 Mar; 80(4):106. PubMed ID: 36952018
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity.
Panyain N; Godinat A; Lanyon-Hogg T; Lachiondo-Ortega S; Will EJ; Soudy C; Mondal M; Mason K; Elkhalifa S; Smith LM; Harrigan JA; Tate EW
J Am Chem Soc; 2020 Jul; 142(28):12020-12026. PubMed ID: 32579346
[TBL] [Abstract][Full Text] [Related]
13. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
[TBL] [Abstract][Full Text] [Related]
15. UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: evidence of interplay between the ubiquitin/proteasome system and autophagy.
Costes S; Gurlo T; Rivera JF; Butler PC
Autophagy; 2014 Jun; 10(6):1004-14. PubMed ID: 24879150
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.
Matuszczak E; Tylicka M; Komarowska MD; Debek W; Hermanowicz A
Cell Biochem Funct; 2020 Jul; 38(5):533-540. PubMed ID: 32207552
[TBL] [Abstract][Full Text] [Related]
17. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration.
Bilguvar K; Tyagi NK; Ozkara C; Tuysuz B; Bakircioglu M; Choi M; Delil S; Caglayan AO; Baranoski JF; Erturk O; Yalcinkaya C; Karacorlu M; Dincer A; Johnson MH; Mane S; Chandra SS; Louvi A; Boggon TJ; Lifton RP; Horwich AL; Gunel M
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3489-94. PubMed ID: 23359680
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites.
Ilic A; Lu S; Bhatia V; Begum F; Klonisch T; Agarwal P; Xu W; Davie JR
Epigenetics Chromatin; 2017 Nov; 10(1):54. PubMed ID: 29126443
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin C-terminal hydrolase L1 (UCHL1), a double-edged sword in mammalian oocyte maturation and spermatogenesis.
Yang D; Lu Q; Peng S; Hua J
Cell Prolif; 2023 Feb; 56(2):e13347. PubMed ID: 36218038
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma.
Tangri A; Lighty K; Loganathan J; Mesmar F; Podicheti R; Zhang C; Iwanicki M; Drapkin R; Nakshatri H; Mitra S
Mol Cancer Res; 2021 Jul; 19(7):1168-1181. PubMed ID: 33753553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
